Bijan Rezakhaniha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bijan Rezakhaniha has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Soheila Siroosbakht
Department of Pediatrics, Golestan Hospital, AJA University of Medical Sciences, Tehran, Iran
19 shared publications - Sadra Rezakhaniha
Department of Nutrition, Science and Research Islamic Azad University, Tehran, Iran
6 shared publications Banafshe Dormanesh
Department of Pediatric Nephrology, AJA University of Medical Sciences, Tehran, Iran
3 shared publicationsFarshad Namdari
Department of Urology Imam Reza Hospital AJA University of Medical Sciences Tehran Iran
3 shared publicationsEmad Yahaghi
Department of Molecular Biology, Baqiyatallah University of Medical Sciences, Tehran, Iran
2 shared publicationsHamid Pirasteh
Department of Nephrology, AJA University of Medical Sciences, Tehran, Iran
2 shared publications
Latest Publications
- Open Access
- 29 June 2026
- Published by Maad Rayan Publishing Company in Journal of Nephropharmacology
- Vol. 15 (2) , e12886
Application of probiotics consumption in patients with kidney and urinary tract diseases; a systematic review of clinical evidence and mechanistic insights
Introduction: Kidney and urinary tract diseases pose a significant health burden, and probiotics, by modulating gut and urogenital microbiota, may offer supportive benefits in this field. This review systematically evaluates the current literature to clarify the role of probiotic consumption in nephrology and urology. Materials and Methods: A systematic review was conducted in accordance with PRISMA guidelines, with comprehensive searches performed in PubMed/MEDLINE, Embase, Scopus, Web of Science, Cochrane Library, and Google Scholar from inception to December 2025 without language restrictions; search strategies combined MeSH terms and keywords for probiotics, kidney diseases, and urinary tract infections (UTIs) using Boolean operators, and additional studies were identified through manual reference list searches; two independent reviewers screened titles, abstracts, and full texts against predefined criteria, extracted data using a standardized form, and assessed methodological quality with the Cochrane Risk of Bias tool for randomized controlled trials and the Newcastle–Ottawa Scale for observational studies. Results: This systematic review of 16 randomized and cross-sectional studies involving 2,667 participants across 12 countries found that probiotics may offer therapeutic benefits in kidney and urinary tract diseases. In chronic kidney disease (CKD) populations, probiotics showed potential in reducing uremic toxins, improving glycemic control, lowering inflammation, and enhancing quality of life, though some studies reported neutral or adverse effects, such as increased interleukin 6 (IL-6) or uremic markers in dialysis patients. In UTI, Lactobacillus-based probiotics were generally safe and effective in reducing recurrence, improving outcomes when combined with antibiotics, and lowering bacterial resistance, although certain strains demonstrated limited or no benefit. Conclusion: In conclusion, probiotics may serve as a safe adjunctive therapy in kidney and urinary tract diseases, but strain- and patient-specific responses as well as optimal formulations, dosing, and long-term effects require confirmation through larger, well-designed trials. Registration: This study has been compiled based on the PRISMA checklist, and its protocol was registered on the PROSPERO (ID: CRD420251273335) and the Research Registry (UIN: reviewregistry2068) websites.
- 29 June 2026
- Published by Maad Rayan Publishing Company in Journal of Nephropharmacology
- Vol. 15 (2) , e12886
Open AccessApplication of probiotics consumption in patients with kidney and urinary tract diseases; a systematic review of clinical evidence and mechanistic insights
Introduction: Kidney and urinary tract diseases pose a significant health burden, and probiotics, by modulating gut and urogenital microbiota, may offer supportive benefits in this field. This review systematically evaluates the current literature to clarify the role of probiotic consumption in nephrology and urology. Materials and Methods: A systematic review was conducted in accordance with PRISMA guidelines, with comprehensive searches performed in PubMed/MEDLINE, Embase, Scopus, Web of Science, Cochrane Library, and Google Scholar from inception to December 2025 without language restrictions; search strategies combined MeSH terms and keywords for probiotics, kidney diseases, and urinary tract infections (UTIs) using Boolean operators, and additional studies were identified through manual reference list searches; two independent reviewers screened titles, abstracts, and full texts against predefined criteria, extracted data using a standardized form, and assessed methodological quality with the Cochrane Risk of Bias tool for randomized controlled trials and the Newcastle–Ottawa Scale for observational studies. Results: This systematic review of 16 randomized and cross-sectional studies involving 2,667 participants across 12 countries found that probiotics may offer therapeutic benefits in kidney and urinary tract diseases. In chronic kidney disease (CKD) populations, probiotics showed potential in reducing uremic toxins, improving glycemic control, lowering inflammation, and enhancing quality of life, though some studies reported neutral or adverse effects, such as increased interleukin 6 (IL-6) or uremic markers in dialysis patients. In UTI, Lactobacillus-based probiotics were generally safe and effective in reducing recurrence, improving outcomes when combined with antibiotics, and lowering bacterial resistance, although certain strains demonstrated limited or no benefit. Conclusion: In conclusion, probiotics may serve as a safe adjunctive therapy in kidney and urinary tract diseases, but strain- and patient-specific responses as well as optimal formulations, dosing, and long-term effects require confirmation through larger, well-designed trials. Registration: This study has been compiled based on the PRISMA checklist, and its protocol was registered on the PROSPERO (ID: CRD420251273335) and the Research Registry (UIN: reviewregistry2068) websites.
- Open Access
- 12 February 2025
- Published by Brieflands in Journal of Comprehensive Pediatrics
- Vol. 16 (1)
Is There a Relationship Between the Vitamin D Status of Newborns and Their Mothers and the Occurrence of Physiological and Out of Physiological Hyperbilirubinemia? A Case-Control Study
Background: The role of vitamin D deficiency in the severity of neonatal hyperbilirubinemia (NH) has been speculative. There are controversies about the association of NH and vitamin D status in neonates and their mothers Objectives: To evaluate the relationship between physiological and out of physiological NH and the vitamin D status of both neonates and their mothers. Methods: This case-control study was conducted with 50 mothers and their healthy term newborns (born after 37 weeks of gestation) with non-physiological NH (case group) and 150 mothers and their healthy term newborns with physiological NH (control group) in Golestal Hospital Tehran, Iran from October 2020 to June 2024. The relationship between the vitamin D status of newborns and mothers and the newborns’ bilirubin levels was defined as the main outcome measures. Blood samples were collected from the subjects between the 3rd-5th days postpartum to measure bilirubin and vitamin D levels. The data was analyzed using a Multivariate logistic Regression analysis to estimate OR at a 95% CI. Results: The neonates and mothers in the case group exhibited significantly lower vitamin D levels compared to those in the control group (27.8 ± 10.04 ng/mL vs. 33.9 ± 9.39 ng/mL, P = 0.006 and 20.56 ± 10.2 ng/mL vs. 26 ± 8.92 ng/mL, P = 0.001, respectively). A significant correlation was observed between neonatal and maternal vitamin D levels in the case and control groups (r = 0.74, P = 0.01 and r = 0.77, P = 0.01, respectively). Moreover, a significant negative correlation was found between the newborns’ bilirubin levels and both neonatal and maternal vitamin D status in the case group (r = -0.34, P = 0.02 and r = -0.21, P = 0.04, respectively). Additionally, a significant negative correlation was observed between the newborns’ bilirubin levels and both neonatal and maternal vitamin D status in the control group (r = -0.41, P = 0.01 and r = -0.42, P = 0.01, respectively). Conclusions: Vitamin D levels were significantly lower in neonates with non-physiological NH, compared to those with physiological NH. Moreover, a significant negative correlation was observed between the newborns’ bilirubin levels and both neonatal and maternal vitamin D status. This correlation was more pronounced in cases of non-physiological NH. It appears that vitamin D levels play a role in NH.
- 12 February 2025
- Published by Brieflands in Journal of Comprehensive Pediatrics
- Vol. 16 (1)
Open AccessIs There a Relationship Between the Vitamin D Status of Newborns and Their Mothers and the Occurrence of Physiological and Out of Physiological Hyperbilirubinemia? A Case-Control Study
Background: The role of vitamin D deficiency in the severity of neonatal hyperbilirubinemia (NH) has been speculative. There are controversies about the association of NH and vitamin D status in neonates and their mothers Objectives: To evaluate the relationship between physiological and out of physiological NH and the vitamin D status of both neonates and their mothers. Methods: This case-control study was conducted with 50 mothers and their healthy term newborns (born after 37 weeks of gestation) with non-physiological NH (case group) and 150 mothers and their healthy term newborns with physiological NH (control group) in Golestal Hospital Tehran, Iran from October 2020 to June 2024. The relationship between the vitamin D status of newborns and mothers and the newborns’ bilirubin levels was defined as the main outcome measures. Blood samples were collected from the subjects between the 3rd-5th days postpartum to measure bilirubin and vitamin D levels. The data was analyzed using a Multivariate logistic Regression analysis to estimate OR at a 95% CI. Results: The neonates and mothers in the case group exhibited significantly lower vitamin D levels compared to those in the control group (27.8 ± 10.04 ng/mL vs. 33.9 ± 9.39 ng/mL, P = 0.006 and 20.56 ± 10.2 ng/mL vs. 26 ± 8.92 ng/mL, P = 0.001, respectively). A significant correlation was observed between neonatal and maternal vitamin D levels in the case and control groups (r = 0.74, P = 0.01 and r = 0.77, P = 0.01, respectively). Moreover, a significant negative correlation was found between the newborns’ bilirubin levels and both neonatal and maternal vitamin D status in the case group (r = -0.34, P = 0.02 and r = -0.21, P = 0.04, respectively). Additionally, a significant negative correlation was observed between the newborns’ bilirubin levels and both neonatal and maternal vitamin D status in the control group (r = -0.41, P = 0.01 and r = -0.42, P = 0.01, respectively). Conclusions: Vitamin D levels were significantly lower in neonates with non-physiological NH, compared to those with physiological NH. Moreover, a significant negative correlation was observed between the newborns’ bilirubin levels and both neonatal and maternal vitamin D status. This correlation was more pronounced in cases of non-physiological NH. It appears that vitamin D levels play a role in NH.
- 31 July 2024
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (1) , 319-335
Unveiling the diagnostic potential of diffusion kurtosis imaging and intravoxel incoherent motion for detecting and characterizing prostate cancer: a meta-analysis
Purpose This study aims to assess the diagnostic capabilities of Diffusion Kurtosis Imaging (DKI) and Intravoxel Incoherent Motion (IVIM) in prostate cancer (PCa) detection and characterization. Materials A comprehensive search was conducted across PubMed, Scopus, Web of Science, and the Cochrane Library for articles published up to September 10, 2023, that evaluated the diagnostic efficacy of MD, MK, Dt, f, and Dp parameters. Data were pooled using a bivariate mixed-effects regression model and analyzed with R software. Results In total, 27 studies were included. The analysis revealed distinct diagnostic efficacies for DKI and IVIM. In the overall model, sensitivity and specificity were 0.807 and 0.797, respectively, with prospective studies showing higher specificity (0.858, p = 0.024). The detection model yielded increased sensitivity (0.845) and specificity (0.812), with DKI outperforming IVIM in both metrics (sensitivity: 0.87, p = 0.043; specificity: 0.837, p = 0.26); MD had high sensitivity (0.88) and specificity (0.82), while MK’s specificity was significantly higher (0.854, p = 0.04); Dp’s sensitivity was significantly lower (0.64, p = 0.016). In characterization, sensitivity and specificity were 0.708 and 0.735, respectively, with no significant differences between DKI and IVIM or Gleason Scores; MK had higher sensitivity (0.78, p = 0.039), and f’s sensitivity was significantly lower (0.51, p = 0.019). Conclusion In summary, the study underscores DKI’s enhanced diagnostic accuracy over IVIM in detecting PCa, with MK standing out for its precision. Conversely, Dp and f lag in diagnostic performance. Despite these promising results, the study highlights the imperative for standardized protocols and study designs to achieve reliable and consistent outcomes.
- 31 July 2024
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (1) , 319-335
Unveiling the diagnostic potential of diffusion kurtosis imaging and intravoxel incoherent motion for detecting and characterizing prostate cancer: a meta-analysis
Purpose This study aims to assess the diagnostic capabilities of Diffusion Kurtosis Imaging (DKI) and Intravoxel Incoherent Motion (IVIM) in prostate cancer (PCa) detection and characterization. Materials A comprehensive search was conducted across PubMed, Scopus, Web of Science, and the Cochrane Library for articles published up to September 10, 2023, that evaluated the diagnostic efficacy of MD, MK, Dt, f, and Dp parameters. Data were pooled using a bivariate mixed-effects regression model and analyzed with R software. Results In total, 27 studies were included. The analysis revealed distinct diagnostic efficacies for DKI and IVIM. In the overall model, sensitivity and specificity were 0.807 and 0.797, respectively, with prospective studies showing higher specificity (0.858, p = 0.024). The detection model yielded increased sensitivity (0.845) and specificity (0.812), with DKI outperforming IVIM in both metrics (sensitivity: 0.87, p = 0.043; specificity: 0.837, p = 0.26); MD had high sensitivity (0.88) and specificity (0.82), while MK’s specificity was significantly higher (0.854, p = 0.04); Dp’s sensitivity was significantly lower (0.64, p = 0.016). In characterization, sensitivity and specificity were 0.708 and 0.735, respectively, with no significant differences between DKI and IVIM or Gleason Scores; MK had higher sensitivity (0.78, p = 0.039), and f’s sensitivity was significantly lower (0.51, p = 0.019). Conclusion In summary, the study underscores DKI’s enhanced diagnostic accuracy over IVIM in detecting PCa, with MK standing out for its precision. Conversely, Dp and f lag in diagnostic performance. Despite these promising results, the study highlights the imperative for standardized protocols and study designs to achieve reliable and consistent outcomes.
- Open Access
- 18 April 2023
- Published by BMJ in BMJ Paediatrics Open
- Vol. 7 (1) , e001899
Limited caffeine consumption as first-line treatment in managing primary monosymptomatic enuresis in children: how effective is it? A randomised clinical trial
Objective Evidence about the negative caffeine effect on enuresis in children remains understudied or poorly understood. The study aimed to investigate the effect of caffeine restriction on the improvement and severity of primary monosymptomatic nocturnal enuresis (PMNE). Design Randomised clinical trial. Setting Two referral hospitals in Tehran, Iran, from 2021 to 2023. Patients Five hundred and thirty-four PMNE children aged 6–15 years (each group 267). Interventions Amount of caffeine consumption was recorded by the feed frequency questionnaire and was estimated by Nutrition 4 software. Caffeine consumption per day in the intervention group was Main outcome measures The effect of limited caffeine consumption on the improvement and severity of PMNE. Results The mean age of the intervention and control groups was 10.9±2.3 and 10.5±2.5 years, respectively. The mean number of bed-wetting before caffeine restriction in the intervention and control group was 3.5 (SD 1.7) times/week and 3.4 (SD 1.9) times/week (p=0.91) and 1 month after intervention were 2.3 (SD 1.8) times/week and 3.2 (SD 1.9) times/week, respectively (p=0.001). Caffeine restriction significantly reduced the severity of enuresis in the intervention group. Fifty-four children (20.2%) improved (dry at night) in caffeine restriction and 18 children (6.7%) in the control group with RR 0.615 at 95% CI 0.521 to 0.726, p=0.001. The caffeine restriction significantly reduced the enuresis in children with a number-needed-to-treat benefit 7.417. It means you must treat 7.417 PMNE children with caffeine limitation to improve one child with enuresis (become dry). Conclusion Caffeine restriction can be helpful in reducing PMNE or its severity. Constructive limitation of caffeine is suggested as one of the first-line treatments in the management of PMNE. Trial registration number IRCT20180401039167N3.
- 18 April 2023
- Published by BMJ in BMJ Paediatrics Open
- Vol. 7 (1) , e001899
Open AccessLimited caffeine consumption as first-line treatment in managing primary monosymptomatic enuresis in children: how effective is it? A randomised clinical trial
Objective Evidence about the negative caffeine effect on enuresis in children remains understudied or poorly understood. The study aimed to investigate the effect of caffeine restriction on the improvement and severity of primary monosymptomatic nocturnal enuresis (PMNE). Design Randomised clinical trial. Setting Two referral hospitals in Tehran, Iran, from 2021 to 2023. Patients Five hundred and thirty-four PMNE children aged 6–15 years (each group 267). Interventions Amount of caffeine consumption was recorded by the feed frequency questionnaire and was estimated by Nutrition 4 software. Caffeine consumption per day in the intervention group was Main outcome measures The effect of limited caffeine consumption on the improvement and severity of PMNE. Results The mean age of the intervention and control groups was 10.9±2.3 and 10.5±2.5 years, respectively. The mean number of bed-wetting before caffeine restriction in the intervention and control group was 3.5 (SD 1.7) times/week and 3.4 (SD 1.9) times/week (p=0.91) and 1 month after intervention were 2.3 (SD 1.8) times/week and 3.2 (SD 1.9) times/week, respectively (p=0.001). Caffeine restriction significantly reduced the severity of enuresis in the intervention group. Fifty-four children (20.2%) improved (dry at night) in caffeine restriction and 18 children (6.7%) in the control group with RR 0.615 at 95% CI 0.521 to 0.726, p=0.001. The caffeine restriction significantly reduced the enuresis in children with a number-needed-to-treat benefit 7.417. It means you must treat 7.417 PMNE children with caffeine limitation to improve one child with enuresis (become dry). Conclusion Caffeine restriction can be helpful in reducing PMNE or its severity. Constructive limitation of caffeine is suggested as one of the first-line treatments in the management of PMNE. Trial registration number IRCT20180401039167N3.
- Open Access
- 21 November 2022
- Published by Wiley in Health Science Reports
- Vol. 5 (6) , e939
A comprehensive comparison of the early and late complications of surgical circumcision in neonates and children: A cohort study
Background and Aims: Major circumcision complications are rare; however, circumcision arouses distress in some special cases. The present study aimed to compare infancy and childhood regarding the frequency and relative risk of early and late complications of circumcision.Methods: This study was a retrospective cohort data analysis including 240 neonates and 240 children referred for circumcision from 2015 to 2021. All circumcisions were performed using the surgical dorsal‐ventral slits method. A Cox proportional hazard model was used to assess the relative risk (RR) of complications at a confidence Interval of 95%.Results: The mean age was 19.32 ± 6.5 days for the neonates and 46.1 ± 8.8 months for the children. In general, complications occurred in 61 boys (12.7%), 40 neonates (8.3%), and 21 children (4.4%) (p˂0.001). Bleeding was the most common early complication in six neonates (2.5%) and three children (1.3%), and meatal stenosis was the most common late complication in 10 neonates (4.2%) and four children (1.6%). Meatal web was observed in 11 neonates (4.6%) and four children (1.6%), and the incomplete removal of the prepuce, as “not very satisfactory”, was also noticed in nine neonates (3.75%) and three children (1.3%). The circumcision complications were significantly more frequent in neonates than in children (RR = 2.6, 95% CI 1.46‐4.71, ppp˂0.03; RR = 2.5, 95% CI 0.8–7.75, p<0.04, respectively).Conclusion: The risk of complications is higher in neonates than children. The incomplete removal of prepuce, meatal web, and meatal stenosis are significantly higher in neonates than in children. Before prohibiting or recommending this procedure, practitioners should provide comprehensive information about its risks and benefits. Parents should weigh up the risks and benefits and make the best decision regarding their personal beliefs and customs.
- 21 November 2022
- Published by Wiley in Health Science Reports
- Vol. 5 (6) , e939
Open AccessA comprehensive comparison of the early and late complications of surgical circumcision in neonates and children: A cohort study
Background and Aims: Major circumcision complications are rare; however, circumcision arouses distress in some special cases. The present study aimed to compare infancy and childhood regarding the frequency and relative risk of early and late complications of circumcision.Methods: This study was a retrospective cohort data analysis including 240 neonates and 240 children referred for circumcision from 2015 to 2021. All circumcisions were performed using the surgical dorsal‐ventral slits method. A Cox proportional hazard model was used to assess the relative risk (RR) of complications at a confidence Interval of 95%.Results: The mean age was 19.32 ± 6.5 days for the neonates and 46.1 ± 8.8 months for the children. In general, complications occurred in 61 boys (12.7%), 40 neonates (8.3%), and 21 children (4.4%) (p˂0.001). Bleeding was the most common early complication in six neonates (2.5%) and three children (1.3%), and meatal stenosis was the most common late complication in 10 neonates (4.2%) and four children (1.6%). Meatal web was observed in 11 neonates (4.6%) and four children (1.6%), and the incomplete removal of the prepuce, as “not very satisfactory”, was also noticed in nine neonates (3.75%) and three children (1.3%). The circumcision complications were significantly more frequent in neonates than in children (RR = 2.6, 95% CI 1.46‐4.71, ppp˂0.03; RR = 2.5, 95% CI 0.8–7.75, p<0.04, respectively).Conclusion: The risk of complications is higher in neonates than children. The incomplete removal of prepuce, meatal web, and meatal stenosis are significantly higher in neonates than in children. Before prohibiting or recommending this procedure, practitioners should provide comprehensive information about its risks and benefits. Parents should weigh up the risks and benefits and make the best decision regarding their personal beliefs and customs.
- 18 October 2022
- Published by Hindawi Limited in Andrologia
- Vol. 54 (11)
Are androstenedione, dihydrotestosterone, thyroid‐stimulating hormone, insulin‐like growth factor I, and insulin‐like growth factor binding protein 3 necessary for isolated micropenis healthy boys' evaluation without any phenotypic abnormalities? A cross‐sectional study
- 18 October 2022
- Published by Hindawi Limited in Andrologia
- Vol. 54 (11)
Are androstenedione, dihydrotestosterone, thyroid‐stimulating hormone, insulin‐like growth factor I, and insulin‐like growth factor binding protein 3 necessary for isolated micropenis healthy boys' evaluation without any phenotypic abnormalities? A cross‐sectional study
- 26 September 2022
- Published by Hindawi Limited in Andrologia
- Vol. 54 (11) , e14605
The evaluation of citral effects on experimental unilateral testicular ischemia/reperfusion injury
This investigation aimed to evaluate the defensive impacts of citral on ischemia/reperfusion (I/R) injury induced by testicular torsion/detorsion (T/D) in rats in an experimental model. The grouping of subjects was as follows: (1) sham, (2) T/D, (3) and (4) T/D plus citral 150 and 300 mg/kg, respectively, and (5) intact (citral 300 mg/kg). T/D was performed by testicular 720 degrees turning for 2 h and then detorsion for 24 h. Blood serum was obtained to assess testosterone and oxidative stress markers, epididymal sperms were collected for sperm staining and sperm analysis, and testicular tissues were examined for histopathology. T/D damage was associated with a remarkable decline in sperm total count, viability, and some velocity parameters in comparison to the sham group (p < 0.05), which could be reversed significantly by citral (p < 0.05). Histopathologically, T/D damage caused severe oedema, haemorrhage, inflammation, and seminiferous tubules disruption, while citral improved significantly the mean seminiferous tubular diameter, Cosentino's score, and Johnsen's score (p < 0.05). I/R injury was associated with significant increased malondialdehyde and oxidative stress index, and also significant reduced total antioxidant capacity and testosterone versus the sham group (p < 0.05), which all were prevented significantly by citral administration (p < 0.05). The outcomes greatly proved that testicular I/R injury could be significantly prevented by citral.
- 26 September 2022
- Published by Hindawi Limited in Andrologia
- Vol. 54 (11) , e14605
The evaluation of citral effects on experimental unilateral testicular ischemia/reperfusion injury
This investigation aimed to evaluate the defensive impacts of citral on ischemia/reperfusion (I/R) injury induced by testicular torsion/detorsion (T/D) in rats in an experimental model. The grouping of subjects was as follows: (1) sham, (2) T/D, (3) and (4) T/D plus citral 150 and 300 mg/kg, respectively, and (5) intact (citral 300 mg/kg). T/D was performed by testicular 720 degrees turning for 2 h and then detorsion for 24 h. Blood serum was obtained to assess testosterone and oxidative stress markers, epididymal sperms were collected for sperm staining and sperm analysis, and testicular tissues were examined for histopathology. T/D damage was associated with a remarkable decline in sperm total count, viability, and some velocity parameters in comparison to the sham group (p < 0.05), which could be reversed significantly by citral (p < 0.05). Histopathologically, T/D damage caused severe oedema, haemorrhage, inflammation, and seminiferous tubules disruption, while citral improved significantly the mean seminiferous tubular diameter, Cosentino's score, and Johnsen's score (p < 0.05). I/R injury was associated with significant increased malondialdehyde and oxidative stress index, and also significant reduced total antioxidant capacity and testosterone versus the sham group (p < 0.05), which all were prevented significantly by citral administration (p < 0.05). The outcomes greatly proved that testicular I/R injury could be significantly prevented by citral.
- Open Access
- 28 August 2022
- Published by Brieflands in Journal of Comprehensive Pediatrics
- Vol. 13 (3)
Establishment of Novel Non-stretched Penile Length (Flaccid) Cut-off Point and Normative Data in Iranian Prepubertal Children and its Significance: Observational Analytical Study
Background: The penile aged-matched value should be determined to define abnormal penile length. Objectives: The purpose of this study was to establish novel reference values and flaccid penis length cut-off points for prepubertal children aged 6 - 15 years. Methods: In this study, 300 micropenis children were studied. In order to assess the diagnostic test power, 300 healthy boys were also evaluated as a control group. All children were divided into ten age groups (60 boys in each group). In order to obtain a non-stretched penile length (NSPL) cut-off point, stretched penile length (SPL) and NSPL mean values were separately calculated for each age group. We subtracted these two values to get the mean difference, which was subtracted from the standard SPL cut-off point to obtain the NSPL cut-off point for each age group. The receiver operating characteristic (ROC) curve and area under the curve (AUC) were defined to assess diagnostic test power. Results: NSPL cut-off point for the age groups of 6 - 7, 7 - 8, 8 - 9, 9 - 10, 10 - 11, 11 - 12, 12 - 13, 13 - 14, 14 - 15, and 15 - 16 years was 2.8, 2.9, 2.9, 3.8, 3.9, 4.4, 4.2, 4.8, 6.6, and 8.1 cm, respectively. Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of NSPL were 100% (95% CI, 98.53 - 100.00), 94.66% (95% CI, 89.77 - 96.28), 7.25% (95% CI, 4.64 - 11.16), 100%, and 97.33% (95% CI, 91.09 - 99.59), respectively. The AUC was 0.82, showing that the diagnostic power of the test was good. Conclusions: This study aimed to attain precise reference values of flaccid penis measurement for children. It seemed that the flaccid method is less observer-dependent, more tolerable, and repeatable. It should be mentioned that this new method does not replace the standard SPL method, while utilizing two reference values together can help to detect the size of the penis more accurately, especially in children. The new cut-off point can be used by all primary care practitioners and pediatric nurses as a reference for prepubertal boys to prevent misdiagnosis or overdiagnosis of micropenis.
- 28 August 2022
- Published by Brieflands in Journal of Comprehensive Pediatrics
- Vol. 13 (3)
Open AccessEstablishment of Novel Non-stretched Penile Length (Flaccid) Cut-off Point and Normative Data in Iranian Prepubertal Children and its Significance: Observational Analytical Study
Background: The penile aged-matched value should be determined to define abnormal penile length. Objectives: The purpose of this study was to establish novel reference values and flaccid penis length cut-off points for prepubertal children aged 6 - 15 years. Methods: In this study, 300 micropenis children were studied. In order to assess the diagnostic test power, 300 healthy boys were also evaluated as a control group. All children were divided into ten age groups (60 boys in each group). In order to obtain a non-stretched penile length (NSPL) cut-off point, stretched penile length (SPL) and NSPL mean values were separately calculated for each age group. We subtracted these two values to get the mean difference, which was subtracted from the standard SPL cut-off point to obtain the NSPL cut-off point for each age group. The receiver operating characteristic (ROC) curve and area under the curve (AUC) were defined to assess diagnostic test power. Results: NSPL cut-off point for the age groups of 6 - 7, 7 - 8, 8 - 9, 9 - 10, 10 - 11, 11 - 12, 12 - 13, 13 - 14, 14 - 15, and 15 - 16 years was 2.8, 2.9, 2.9, 3.8, 3.9, 4.4, 4.2, 4.8, 6.6, and 8.1 cm, respectively. Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of NSPL were 100% (95% CI, 98.53 - 100.00), 94.66% (95% CI, 89.77 - 96.28), 7.25% (95% CI, 4.64 - 11.16), 100%, and 97.33% (95% CI, 91.09 - 99.59), respectively. The AUC was 0.82, showing that the diagnostic power of the test was good. Conclusions: This study aimed to attain precise reference values of flaccid penis measurement for children. It seemed that the flaccid method is less observer-dependent, more tolerable, and repeatable. It should be mentioned that this new method does not replace the standard SPL method, while utilizing two reference values together can help to detect the size of the penis more accurately, especially in children. The new cut-off point can be used by all primary care practitioners and pediatric nurses as a reference for prepubertal boys to prevent misdiagnosis or overdiagnosis of micropenis.
- 2 August 2021
- Published by Hindawi Limited in Andrologia
- Vol. 53 (10) , e14200
Is there relationship between serum uric acid levels and lower urinary tract symptoms, prostate volume, and PSA in men without cancer? A prospective population‐based study
There are conflicting results about uric acid (UA) effect on the prostate. We investigated the relationship between UA and PSA, free PSA, prostate volume and international prostate symptoms score (IPSS) in benign prostate hyperplasia (BPH). This study was conducted in BPH men without cancer who were referred for annual health workup (N = 910) from 2017 to 2020. The mean ages were 67.28 ± 9.2 years. UA was positively related to IPSS and PSA (r = 0.210, p = .023 and r = 0.156, p = .041 respectively) and also negatively related to free/total PSA ratio (r = −0.332, p = .01) but not related to prostate volume (r = 0.036, p = .696). After adjustment for age, BMI and prostate volume, there were significant relationships between hyperuricaemia and PSA, free/total PSA ratio, and IPSS (95% CI: 0.254–1.645, OR = 0.647, p = .039; 95% CI: 0.076–0.899, OR = 0.270, p = .033 and 95% CI: 1.011–3.386, OR = 1.851, p = .038 respectively). These results should be considered during the general assessment of the patients with BPH. The findings raise the possible hypothesis of relationship between serum UA with IPSS and PSA which should be investigated by future studies.
- 2 August 2021
- Published by Hindawi Limited in Andrologia
- Vol. 53 (10) , e14200
Is there relationship between serum uric acid levels and lower urinary tract symptoms, prostate volume, and PSA in men without cancer? A prospective population‐based study
There are conflicting results about uric acid (UA) effect on the prostate. We investigated the relationship between UA and PSA, free PSA, prostate volume and international prostate symptoms score (IPSS) in benign prostate hyperplasia (BPH). This study was conducted in BPH men without cancer who were referred for annual health workup (N = 910) from 2017 to 2020. The mean ages were 67.28 ± 9.2 years. UA was positively related to IPSS and PSA (r = 0.210, p = .023 and r = 0.156, p = .041 respectively) and also negatively related to free/total PSA ratio (r = −0.332, p = .01) but not related to prostate volume (r = 0.036, p = .696). After adjustment for age, BMI and prostate volume, there were significant relationships between hyperuricaemia and PSA, free/total PSA ratio, and IPSS (95% CI: 0.254–1.645, OR = 0.647, p = .039; 95% CI: 0.076–0.899, OR = 0.270, p = .033 and 95% CI: 1.011–3.386, OR = 1.851, p = .038 respectively). These results should be considered during the general assessment of the patients with BPH. The findings raise the possible hypothesis of relationship between serum UA with IPSS and PSA which should be investigated by future studies.
- Open Access
- 3 January 2021
- Published by Brieflands in Iranian Journal of Pediatrics
- Vol. 31 (1)
Which of the Anthropometric Parameters and Hormonal Variables in Prepubertal Children Are Correlated to True Micropenis?
Background: Most issues of micropenis boys include poor body image and quality of life. Objectives: The purpose of this assay was to survey the relationship of anthropometric measures, testosterone, estradiol, gonadotropins and prolactin with stretched penile length (SPL) and flaccid glans-pubis length (GPL) in pre-pubertal boys with true small penis. Methods: This was prospective a cross-sectional observational study that was conducted in Imam Reza Hospital, Tehran, Iran from February 2015 to May 2020. The pre-pubertal children 7 - 14 years who referred with small penis size were evaluated by a pediatrician and urologist and, if they had true micropenis, they were enrolled in the study (n = 236). The anthropometric and hormonal measurements, SPL, GPL, and relationship of these variables were evaluated. Results: Mean ages of children were 11.65 ± 1.59 years. Mean SPL and GPL were 2.95 ± 1.23 and 2.29 ± 1.06 cm, respectively. There was a significant relationship between SPL and GPL (r = 0.976, P = 0.000). SPL and GPL were not correlated with BMI (r = -0.182, P = 0.054; r = -0.161, P = 0.089, respectively). A significant correlation was found between SPL and GPL with height, FSH, LH, Testosterone and T/E ratio (P < 0.01) but no correlation with weight, estradiol and prolactin (> 0.05). Conclusions: According to the finding of present study, the flaccid measurement can be as helpful as stretched measurement if it is done from pubic bone to tip of glans. Retraining of primary health workers about age-related penile length may be reducing the misdiagnosis of micropenis and concerns of parents, especially in obese boys. The penile length in prepubertal children was not related to BMI and weight but was significantly related to height. Furthermore, Estradiol level is not related to penile length in children with micropenis.
- 3 January 2021
- Published by Brieflands in Iranian Journal of Pediatrics
- Vol. 31 (1)
Open AccessWhich of the Anthropometric Parameters and Hormonal Variables in Prepubertal Children Are Correlated to True Micropenis?
Background: Most issues of micropenis boys include poor body image and quality of life. Objectives: The purpose of this assay was to survey the relationship of anthropometric measures, testosterone, estradiol, gonadotropins and prolactin with stretched penile length (SPL) and flaccid glans-pubis length (GPL) in pre-pubertal boys with true small penis. Methods: This was prospective a cross-sectional observational study that was conducted in Imam Reza Hospital, Tehran, Iran from February 2015 to May 2020. The pre-pubertal children 7 - 14 years who referred with small penis size were evaluated by a pediatrician and urologist and, if they had true micropenis, they were enrolled in the study (n = 236). The anthropometric and hormonal measurements, SPL, GPL, and relationship of these variables were evaluated. Results: Mean ages of children were 11.65 ± 1.59 years. Mean SPL and GPL were 2.95 ± 1.23 and 2.29 ± 1.06 cm, respectively. There was a significant relationship between SPL and GPL (r = 0.976, P = 0.000). SPL and GPL were not correlated with BMI (r = -0.182, P = 0.054; r = -0.161, P = 0.089, respectively). A significant correlation was found between SPL and GPL with height, FSH, LH, Testosterone and T/E ratio (P < 0.01) but no correlation with weight, estradiol and prolactin (> 0.05). Conclusions: According to the finding of present study, the flaccid measurement can be as helpful as stretched measurement if it is done from pubic bone to tip of glans. Retraining of primary health workers about age-related penile length may be reducing the misdiagnosis of micropenis and concerns of parents, especially in obese boys. The penile length in prepubertal children was not related to BMI and weight but was significantly related to height. Furthermore, Estradiol level is not related to penile length in children with micropenis.